WHO warns of contaminated India cough syrups
Sign up now: Get ST's newsletters delivered to your inbox
Indian authorities have asked people to avoid cough syrups, including ReLife and Coldrif (right), which had been linked to the deaths of several children.
PHOTO: REUTERS
Follow topic:
GENEVA - The World Health Organisation on Oct 13 issued a health advisory warning about three contaminated cough syrups identified in India, urging authorities to report any detection of these medicines in their countries to the health agency.
The WHO said the affected medicines are specific batches of Coldrif from Sresan Pharmaceutical, Respifresh TR from Rednex Pharmaceuticals and ReLife from Shape Pharma.
The agency said the contaminated products pose significant risks and can cause severe, potentially life-threatening illness.
India's health authority, the Central Drugs Standard Control Organisation, informed the WHO the syrups were reportedly consumed by children
The cough medicine contained toxic diethylene glycol in quantities nearly 500 times the permissible limit.
CDSCO said none of the contaminated medicines have been exported from India and there is no evidence of illegal export.
The US Food and Drug Administration confirmed on Oct 10 that these toxic cough syrups had not been shipped to the United States. REUTERS
